Clinical trial
Ecopipam Treatment of Pathological Gambling
NCT01215357 is registered in ClinicalTrials.gov with Emalex Biosciences Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ecopipam Treatment of Pathological Gambling
- Lead sponsor
- Emalex Biosciences Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 34 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
pathological gambling